Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01315236
Show Display Options
Rank Status Study
1 Completed Arikayce for Nontuberculous Mycobacteria
Condition: Mycobacterium Infections, Nontuberculous
Interventions: Drug: Liposomal amikacin for inhalation (LAI);   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.